FLGT – fulgent genetics, inc. (US:NASDAQ)
Stock Stats
News
Fulgent Genetics: From Genetic Code To Cancer Cure - Why I Assign A Hold Rating [Seeking Alpha]
Fulgent Genetics (NASDAQ:FLGT) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Fulgent Genetics (NASDAQ:FLGT) had its price target raised by analysts at Piper Sandler from $21.00 to $30.00. They now have a "neutral" rating on the stock.
Fulgent Genetics, Inc. (FLGT) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Fulgent Genetics Inc (FLGT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Upward ... [Yahoo! Finance]
Form 4 Fulgent Genetics, Inc. For: Dec 02 Filed by: Xie Jian
Form 4 Fulgent Genetics, Inc. For: Dec 01 Filed by: Kim Paul
Form 4 Fulgent Genetics, Inc. For: Dec 02 Filed by: Gao Hanlin
Form 4 Fulgent Genetics, Inc. For: Nov 28 Filed by: Xie Jian
Form 144 Fulgent Genetics, Inc. Filed by: Gao Hanlin
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.